Reduced kidney excretion
Typical setting: Acute kidney injury, chronic kidney disease, or low distal tubular flow.
The distal nephron cannot secrete enough potassium into urine.
Hyperkalaemia module
Understand hyperkalaemia as excess extracellular potassium reducing cardiac electrical stability, with kidney failure, cell shift, drugs, acidosis, and urgent membrane protection at the centre.
Clinically reviewed by Mark · NMC-registered nurse
Aetiology
Hyperkalaemia usually reflects impaired excretion, movement out of cells, increased load, or a false laboratory rise.
Typical setting: Acute kidney injury, chronic kidney disease, or low distal tubular flow.
The distal nephron cannot secrete enough potassium into urine.
Typical setting: ACE inhibitors, ARBs, spironolactone, eplerenone, amiloride, trimethoprim, heparin, and NSAIDs.
Aldosterone effect or renal perfusion is reduced, so potassium secretion falls.
Typical setting: Acidosis, insulin deficiency, beta-blockade, rhabdomyolysis, tumour lysis, burns, or haemolysis.
Intracellular potassium moves into extracellular fluid or is released by cell injury.
Typical setting: Supplements, salt substitutes, or high-potassium intake in kidney disease.
Input exceeds excretory reserve, especially when renal or aldosterone pathways are impaired.
Typical setting: Haemolysed sample, difficult venepuncture, severe thrombocytosis, or leukocytosis.
Potassium rises in the sample rather than in the patient.
Mechanism chain
The immediate danger is electrical; the lasting fix depends on why potassium rose.
Potassium rises when kidney excretion is inadequate, cells release potassium, or aldosterone-dependent secretion is blocked.
The extracellular potassium concentration increases despite most body potassium remaining intracellular.
Keep exploring